Similar Search Results

Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

Hens, Manuel; Villaverde-Hueso, Ana; Alonso, Veronica; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 433-437

Persistent link: https://www.econbiz.de/10010383394

The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England

Meng, Yang; Hertel, Nadine; Ellis, John; Morais, Edith; … - In: The European journal of health economics : HEPAC ; … 19 (2018) 8, pp. 1163-1172

Persistent link: https://www.econbiz.de/10011948237

Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care : population-based Cohort study and Markov model

Gulliford, Martin C.; Charlton, Judith; Bhattarai, Nawaraj - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 341-351

Persistent link: https://www.econbiz.de/10010360838

Use of POHEM to estimate direct medical costs of current practice and new treatments associated with lung cancer in Canada

Houle, Christian (contributor) - 1997

Persistent link: https://www.econbiz.de/10000960056

Use of Pohem to Estimate Direct Medical Costs of Current Practice and New Treatments Associated with Lung Cancer in Canada

Houle, Christian; Will, B. P.; Berthelot, Jean-Marie; … - 2008

Context: Lung cancer has been the leading cause of cancer deaths in Canadian males for many years, and since 1994, this … treatment of lung cancer calculated through the use of a micro-simulation model. For disease incidence, 1992 was chosen as the … reference year, whereas costs are evaluated according to the rates that prevailed in 1993. Methods: A model for lung cancer has …

Persistent link: https://www.econbiz.de/10014219843